Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bofinger, D. P.
Right arrow Articles by Olson, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bofinger, D. P.
Right arrow Articles by Olson, J. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 62, 299-314 (2001)
Copyright © 2001 by the Society of Toxicology


REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY

Effect of TCDD Exposure on CYP1A1 and CYP1B1 Expression in Explant Cultures of Human Endometrium

Diane P. Bofinger*,1, Li Feng*, Lai-Har Chi*, John Love*, Frank D. Stephen{dagger}, Thomas R. Sutter§, Kevin G. Osteen, Theodore G. Costich{ddagger}, Ronald E. Batt{ddagger}, Stephen T. Koury* and James R. Olson{dagger}

* Department of Biotechnical and Clinical Laboratory Science, {dagger} Department of Pharmacology and Toxicology, and {ddagger} Department of Gynecology-Obstetrics, State University of New York at Buffalo, Buffalo, New York 14214; § W. Harry Feinstone Center for Genomic Research, University of Memphis, Memphis, Tennessee 38152; and Women's Reproductive Health Research Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

Endometriosis is a debilitating disease estimated to affect 10% of reproductive-age women and characterized by the growth of endometrial tissue outside of the uterus. The present study characterizes a human endometrial explant culture model for studying the direct effects of TCDD exposure by assessing the expression of CYP1A1 and CYP1B1 mRNA (Northern blotting), protein (Western blotting), and activity (7-ethoxyresorufin-O-deethylase; EROD) in explants cultured with and without TCDD. Explants were obtained at laparoscopy or laparotomy from women undergoing surgery for tubal ligation, endometriosis, or pelvic pain unrelated to endometriosis. The explants were cultured with 10 nM estradiol (E2) or 1 nM E2 plus 500 nM progesterone (P4) with or without TCDD (first 24 h). The expression of CYP1A1 and CYP1B1 mRNA was greatest with 10 nM TCDD and increased up to 72 h after initial exposure. EROD activity increased up to 120 h. Explants from a secretory phase biopsy became reorganized in culture and formed a new epithelial membrane, while maintaining basic endometrial morphology and viability for up to 120 h. At 24 h, TCDD significantly increased CYP1A1 and CYP1B1 mRNA, and at 72 h, TCDD significantly increased EROD activity and CYP1B1 protein compared to explants cultured without TCDD for similar times. CYP1B1 protein also exhibited substantial constitutive expression that was similar in uncultured biopsies, where CYP1B1 protein was immunolocalized in the cytoplasm of epithelial glands, with only occasional patches of protein in the surface epithelial membrane. In explants cultured with and without TCDD exposure, CYP1B1 protein was localized in the cytoplasm of the new surface epithelial membrane and glands closest to the surface. CYP1A1 protein was not detected in uncultured biopsies or explants. Both younger age (age 30 and under) and proliferative phase were associated with higher TCDD-induced EROD activity in specimens treated with E2:P4. No significant endometriosis-related differences were observed for any of the biomarkers, but the detection of disease-specific change was limited by small sample size and variability in tissue-cycle phase. The human endometrial explant culture model will be useful for future studies of the effects of dioxin-like compounds on human endometrium in relationship to cycle phase and hormonal exposure.

Key Words: endometrium; endometriosis; dioxin; 2,3,7,8-tetrachlorodibenzo-p-dioxin; TCDD; CYP1A1; CYP1B1; cytochrome P450 enzymes; cytochrome P450 1A1; cytochrome P450 1B1..


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
J. K. Jain, A. Li, W. Yang, P. Minoo, and J. C. Felix
Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate
Hum. Reprod., March 1, 2006; 21(3): 798 - 809.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Thibaudeau, J. Lepine, J. Tojcic, Y. Duguay, G. Pelletier, M. Plante, J. Brisson, B. Tetu, S. Jacob, L. Perusse, et al.
Characterization of Common UGT1A8, UGT1A9, and UGT2B7 Variants with Different Capacities to Inactivate Mutagenic 4-Hydroxylated Metabolites of Estradiol and Estrone
Cancer Res., January 1, 2006; 66(1): 125 - 133.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S.-W. Guo
Glutathione S-transferases M1/T1 gene polymorphisms and endometriosis: a meta-analysis of genetic association studies
Mol. Hum. Reprod., October 1, 2005; 11(10): 729 - 743.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. D. Mueller, J.-L. Vigne, M. Streich, M. K. Tee, L. Raio, E. Dreher, N. A. Bersinger, and R. N. Taylor
2,3,7,8-Tetrachlorodibenzo-p-Dioxin Increases Glycodelin Gene and Protein Expression in Human Endometrium
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4809 - 4815.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Lepine, O. Bernard, M. Plante, B. Tetu, G. Pelletier, F. Labrie, A. Belanger, and C. Guillemette
Specificity and Regioselectivity of the Conjugation of Estradiol, Estrone, and Their Catecholestrogen and Methoxyestrogen Metabolites by Human Uridine Diphospho-glucuronosyltransferases Expressed in Endometrium
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5222 - 5232.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. Rylander-Rudqvist, S. Wedren, G. Jonasdottir, S. Ahlberg, E. Weiderpass, I. Persson, and M. Ingelman-Sundberg
Cytochrome P450 1B1 Gene Polymorphisms and Postmenopausal Endometrial Cancer Risk
Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1515 - 1520.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. Gibson, J. H. Gill, P. A. Khan, J. M. Seargent, S. W. Martin, P. A. Batman, J. Griffith, C. Bradley, J. A. Double, M. C. Bibby, et al.
Cytochrome P450 1B1 (CYP1B1) Is Overexpressed in Human Colon Adenocarcinomas Relative to Normal Colon: Implications for Drug Development
Mol. Cancer Ther., June 1, 2003; 2(6): 527 - 534.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Rier and W. G. Foster
Environmental Dioxins and Endometriosis
Toxicol. Sci., December 1, 2002; 70(2): 161 - 170.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. A. Pitt, L. Feng, B. D. Abbott, J. Schmid, R. E. Batt, T. G. Costich, S. T. Koury, and D. P. Bofinger
Expression of AhR and ARNT mRNA in Cultured Human Endometrial Explants Exposed to TCDD
Toxicol. Sci., August 1, 2001; 62(2): 289 - 298.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.